MR编号 | SE/H/2331/002 |
---|
药品名称 | Airfonsib |
---|
活性成分 | - beclometasone dipropionate 200.0 µg/dose
- Formoterolfumarat dihydrate 6.0 µg/dose
|
---|
剂型 | Pressurised inhalation, solution |
---|
上市许可持有人 | Sandoz A/S
Edvard Thomsens Vej 14, 2300, Copenhagen S, Denmark |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Romania (RO)
- Netherlands (NL)
- Slovakia (SK)
- France (FR)
- Slovenia (SI)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
- Estonia (EE)
- Croatia (HR)
- Czechia (CZ)
Airfonsib - Germany (DE)
BecloFormAir - Hungary (HU)
|
---|
许可日期 | 2024/04/29 |
---|
最近更新日期 | 2024/05/20 |
---|
药物ATC编码 | - R03AK08 formoterol and beclometasone
|
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Withdrawn(注:已撤市) |
---|